SCHEMBL7744677

SCHEMBL7744677

CC(=O)Nc1oc(-c2ncccc2-c2cccc(C(F)(F)F)c2)nc1-c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDR P35968 7/20 0.53
FLT1 P17948 1/20 0.53
FLT4 P35916 1/20 0.53
TOP2A P11388 1/20 0.46
TRPV1 Q8NER1 1/20 0.43
ADORA2A P29274 1/20 0.42
ADORA1 P30542 1/20 0.42
RXRA P19793 2/20 0.42
RXRB P28702 2/20 0.42
RXRG P48443 2/20 0.42
TLR7 Q9NYK1 1/20 0.41
ADCY1 Q08828 1/20 0.40
MC4R P32245 1/20 0.40
KMO O15229 1/20 0.40
RORC P51449 1/20 0.40
RORB Q92753 1/20 0.40
ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7744174 0.87 KDR (0.66) KDRFLT1FLT4TOP2AADORA2A
SCHEMBL7746644 0.87 KDR (0.62) KDRFLT1FLT4ALDH1A1
SCHEMBL7738998 0.86 KDR (0.57) KDRFLT1FLT4ADORA1RXRA
SCHEMBL7744177 0.85 KDR (0.67) KDRFLT1FLT4ADORA2AADORA1
SCHEMBL7739021 0.83 KDR (0.67) KDRFLT1FLT4ADORA2AADORA1
SCHEMBL7746657 0.82 KDR (0.53) KDRFLT1FLT4ALDH1A1
SCHEMBL7746620 0.78 KDR (0.57) KDRFLT1FLT4TOP2ATRPV1
SCHEMBL14148561 0.76 TP53 (0.50) KDRFLT1FLT4ADORA2AADORA1
SCHEMBL7746616 0.75 KDR (0.65) KDRFLT1FLT4ALDH1A1
SCHEMBL7744668 0.74 KDR (0.69) KDRFLT1FLT4ADORA1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP disclosed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP disclosed
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US disclosed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO disclosed